FDA announces new safety recommendations for high-dose simvastatin

Posted by Food and Drug Administration--Press Releases on Wednesday Jun 8, 2011 Under News

The U.S. Food and Drug Administration today is announcing safety label changes for the cholesterol-lowering medication simvastatin because the highest approved dose–80 milligram (mg)–has been associated with an elevated risk of muscle injury or myopathy, particularly during the first 12 months of use.

Be Sociable, Share!

Comments are closed.